rethinkTHC Search
Menu
Study breakdown

Traumatic Brain Injury Disrupts the Brain's Endocannabinoid System, Worsening Damage

Animal StudyPreliminary evidence
The takeaway

After traumatic brain injury in mice, endocannabinoid levels dropped due to increased metabolizing enzyme activity, which was associated with brain barrier damage, reduced blood flow, and anxiety-like behavior.

Researchers studying brain injury treatment and people interested in the endocannabinoid system's role in neuroprotection

Endocannabinoid depletion after TBI

What the researchers found

TBI increased expression of enzymes that break down endocannabinoids (MAGL, FAAH, Cox-2), leading to reduced 2-AG and AEA levels in plasma. This was accompanied by compromised brain-CSF barrier integrity, increased neuroinflammatory markers (IBA1, GFAP), reduced cerebral blood flow, altered aquaporin-4 expression, reduced ventricular volume, motor deficits, and anxiety behaviors. Preliminary human CSF data also showed endocannabinoid changes after TBI.

Why it matters

TBI affects millions annually with limited treatment options. If endocannabinoid loss after brain injury worsens outcomes, then blocking the enzymes that break down endocannabinoids could represent a new therapeutic approach to reduce secondary brain damage.

The numbers in context

Reduced 2-AG and AEA plasma levels; increased MAGL, FAAH, and Cox-2; increased CB2 and TRPV1 expression; increased AQP4, IBA1, GFAP; reduced cerebral blood flow; reduced ventricular volume; motor deficits and anxiety behaviors; preliminary human data corroborative

How the study worked

Controlled cortical impact mouse model of TBI. Measured endocannabinoid levels and metabolizing enzymes in brain tissue. Assessed brain-CSF barrier integrity, cerebral blood flow, neuroinflammation markers, ventricular volume, and behavior. Preliminary analysis of human CSF and plasma endocannabinoid levels included.

What this study cannot tell us

Mouse CCI model represents one specific type of TBI and may not reflect the full spectrum of human head injuries. Human data is preliminary and not fully detailed. Cannot determine whether endocannabinoid changes cause secondary damage or are simply a marker of injury severity.

How to read the evidence

Comprehensive preclinical study with multiple outcome measures and preliminary human data, but animal model limits direct clinical application

When this study was published

2023 study

The bigger picture

The endocannabinoid system appears to be a natural neuroprotective mechanism that becomes depleted after brain injury. Understanding this depletion could lead to drugs that boost endocannabinoid levels (such as FAAH or MAGL inhibitors) as treatments for the chronic consequences of TBI.

Questions still open

  • Would FAAH or MAGL inhibitors given after TBI improve outcomes? At what time point post-injury would endocannabinoid-boosting therapy be most effective? Do different types of TBI produce different endocannabinoid changes?

Common questions

Could cannabis help after a brain injury?
This study suggests the body's natural cannabinoid system becomes depleted after brain injury, and this depletion may worsen outcomes. However, using cannabis directly after TBI has not been tested and could have unpredictable effects.
What happens to endocannabinoids after brain injury?
The brain ramps up production of enzymes that break down endocannabinoids, causing their levels to drop. This loss of natural neuroprotective compounds was associated with brain barrier damage, inflammation, and behavioral problems in mice.

Read the original research

Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.

Experimental neurology, 361, 114320

Citation

Ahluwalia, Meenakshi; Mcmichael, Hannah; Kumar, Manish; Espinosa, Mario P; Bosomtwi, Asamoah; Lu, Yujiao; Khodadadi, Hesam; Jarrahi, Abbas; Khan, Mohammad Badruzzaman; Hess, David C; Rahimi, Scott Y; Vender, John R; Vale, Fernando L; Braun, Molly; Baban, Babak; Dhandapani, Krishnan M; Vaibhav, Kumar. (2023). Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice.. Experimental neurology, 361, 114320. https://doi.org/10.1016/j.expneurol.2023.114320

Explore the wider topic